Interviews of patients (Pts) with relapsed or refractory (R/R) large B-cell lymphoma (LBCL) enrolled in 2 lisocabtagene maraleucel (liso-cel) trials on their treatment experience for 3 months after infusion Meeting Abstract


Authors: Siddiqi, T.; Jaeger, U.; Moshkovich, O.; Braverman, J.; Liu, F. F.; Lanar, S.; Miera, M.; Shah, S.; Devlen, J.; Salles, G.
Abstract Title: Interviews of patients (Pts) with relapsed or refractory (R/R) large B-cell lymphoma (LBCL) enrolled in 2 lisocabtagene maraleucel (liso-cel) trials on their treatment experience for 3 months after infusion
Meeting Title: 63rd Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 138
Issue: Suppl. 1
Meeting Dates: 2021 Dec 11-14
Meeting Location: Atlanta, GA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2021-11-23
Language: English
ACCESSION: WOS:000835740100099
DOI: 10.1182/blood-2021-151823
PROVIDER: wos
Notes: Meeting Abstract: 4098 -- Hybrid meeting, also took place online -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gilles Andre Salles
    309 Salles